Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/trf.17195 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Recognizing the microgranular variant of acute promyelocytic leukemia when considering leukapheresis.
Transfusion
February 2023
Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.
Onco Targets Ther
March 2017
Institute of Hematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) with a unique morphological appearance, associated coagulopathy and canonical balanced translocation of genetic material between chromosomes 15 and 17. APL was first described as a distinct subtype of AML in 1957 by Dr Leif Hillestad who recognized the pattern of an acute leukemia associated with fibrinolysis, hypofibrinogenemia and catastrophic hemorrhage. In the intervening years, the characteristic morphology of APL has been described fully with both classical hypergranular and variant microgranular forms.
View Article and Find Full Text PDFAcute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping.
Pol J Pathol
March 2012
CSI Laboratories, Alpharetta, GA 30004, USA.
A total of 97 acute promyelocytic leukemia (APL) patients with adequate flow cytometry (FC) data, bone marrow aspirates and presence of t(15;17)/PML-RARA by cytogenetics and/or FISH studies were analyzed for immunophenotypic pattern. Leukemic cells had the following phenotype: CD11b-, CD11c-, CD13+, CD33+, CD45+, CD64+/-, CD117+, and HLA-DR-. A subset of cases showed also an expression of CD2, CD4, CD34, and CD56.
View Article and Find Full Text PDFA rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis.
BMC Microbiol
August 2011
INIBIC-Complejo Hospitalario Universitario A Coruña, Unidad de Genética, As Xubias 84, 15006- A Coruña, Spain.
Background: Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Nevertheless, resistant strains increase dramatically, with serious economic impact and effects on public health, and are responsible for thousands of deaths each year. Critical clinical situations should benefit from a rapid procedure to evaluate the sensitivity or resistance to antibiotics that act at the cell wall.
View Article and Find Full Text PDFImmunophenotypic pattern of myeloid populations by flow cytometry analysis.
Methods Cell Biol
November 2011
Genzyme Genetics (New York Laboratory), New York, NY, USA.
We present our experience with immunophenotypic characteristics of benign and malignant myeloid populations, with emphasis on differential diagnosis especially between eosinophils, dysplastic granulocytes, neoplastic promyelocytes, and monocytes. Eosinophils are characterized by bright CD45, high side scatter (SSC), very low forward scatter (FSC), positive CD11b, CD11c, CD13, CD15, and CD33. They are negative for CD10, CD14, CD16, CD56, CD64, and HLA-DR.
View Article and Find Full Text PDF